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Abstract
Hemophilia represent  the most severe inherited bleeding   disorder (INB) ,  it’s thought  to 
affect  inviduals  from  all  geographical  areas  in  equal  frequency.  In  Egypt  which  has  a 
population  of  approximately  (80million)  consanguineous  marriage  are  frequent,  therefore 
autosomal  recessive  coagulation  disorders  reach  a  higher  prevalence  than  in  many  other 
countries.
The primary aim of this study was to describe the epidemiological situation of hemophilia in 
Mansoura, Egypt ,as based on retrospective analysis of clinical records Mansoura University 
Children Hospital between years 2000 and 2008. The second aim was to assess the o
complications and occurrence of hepatitis C in those patients and relate this status to the type 
of replacement therapy received prior to the study.
The study included 72 children with hematological disorders registered from 2000 to 2008 in 
MUCH. The hemophilic patient was defined as a person with physician
A or B and a measured factor VIII or IX activity level of 30% or less. Persons with acquired 
inhibitors  of  FVIII  or  FIX  excluded.  Severity  level  was  categorized  as  mild  if 
activity level was 6–30%, moderate if 1
The severe presentation represents the majority in 76.7% followed by moderate severity in 
17.2%.The commonest IBDs was hemophilia A affecting 44 patients, followed by Hemop
B affecting 15 patients. The rare types were Factor XI deficiency, Factor V deficiency, Factor 
VII  deficiency  and  combined    FVIII,  FIX  and  FX  deficiency.  The  commonest  orthopedic 
manifestation needing therapy was found among hemophilia A representing
C viremia detected by PCR was found in 11.1% of patients. The bleeding complications as 
hematoma or hemarthrosis were the common complications. Nevertheless, 44.4% of patients 
had no complications,
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y aim of this study was to describe the epidemiological situation of hemophilia in 
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Children Hospital between years 2000 and 2008. The second aim was to assess the orthopedic 
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The study included 72 children with hematological disorders registered from 2000 to 2008 in 
diagnosed hemophilia 
A or B and a measured factor VIII or IX activity level of 30% or less. Persons with acquired 
inhibitors  of  FVIII  or  FIX  excluded.  Severity  level  was  categorized  as  mild  if  the  factor 
The severe presentation represents the majority in 76.7% followed by moderate severity in 
17.2%.The commonest IBDs was hemophilia A affecting 44 patients, followed by Hemophilia 
B affecting 15 patients. The rare types were Factor XI deficiency, Factor V deficiency, Factor 
VII  deficiency  and combined    FVIII,  FIX  and  FX  deficiency.  The  commonest  orthopedic 
8.3%. Hepatitis 
C viremia detected by PCR was found in 11.1% of patients. The bleeding complications as 
hematoma or hemarthrosis were the common complications. Nevertheless, 44.4% of patients Medit J Hemat Infect Dis 2010; 2(3); Open Journal System 
From this study we can conclude that the most common IBDs in our locality is hemophilia A 
followed by hemophilia B. The common presenting symptom was  bleeding following male 
circumcision. Hepatitis C infection and arthropathy represented the main complications. The 
discovery  of  IBDs  in  young  age children  with  proper  supportive  therapy  could  prevent 
arthropathy. Proper screening of blood and blood products reduce the risk of viral hepatitis 
and HIV acquisition.
Introduction: Inherited bleeding disorders (IBDs) 
are  caused  by  quantitative  and  qualitative 
alterations  of  either  platelets  or  plasma  proteins 
involved in coagulation and fibrinolysis.
Hemophilias  are  the  most  frequent  IBD.  The 
congenital bleeding disorders haemophilia A and B 
are estimated to affect between one in 10 000 and 
one in 50000 males.
1
Studies  of  these  diseases  revealed  that  they 
result in varying degrees of bleeding diathesis. This 
deserves  attention,  not  only  to  quantitative 
abnormalities but also to some IBDs, which reflect 
the synthesis of dysfunctional coagulation proteins 
or production of abnormal platelets.
2
Hemophilias  are  the  most  frequent  IBDs. 
However,  von  Willebrand  disease  (VWD)  and 
platelet function  defects  (PFDs)  are less  common 
causes  of  bleeding. Various studies have reported 
that VWD is the most common congenital bleeding 
disorder in the population.
1,3,4
In  Egypt  which  has  a  population  of 
approximately  (80 million)  consanguineous 
marriage  are  frequent,  there  fore  autosomal
recessive  coagulation  disorders  reach  a  higher 
prevalence than in many other countries.
According to survey from the world federation 
of  hemophilia  (WFN)  80%  of  persons  with 
hemophilia in the world are receiving minimal or no 
treatment  at  all  and  often  do not  survive  to 
adulthood,  recently  mortality  among  people  with 
hemophilia  declined  substantially,  this  decline  is 
owed  to  increased  availability  of  clotting  factors 
concentrates  for  the  treatment  of  life  threatening 
bleeding  episodes  and  the  improved  management 
provided  by  specialised  hemophilia  treatment 
centers.
The primary aim of this study was to describe 
the  epidemiological  situation  of  hemophilia  in 
Mansoura , Egypt as based on retrospective analysis 
of clinical records at Mansoura University children 
hospital between 2000 and 2008. The hospital serve 
all  east  Delta  region  including(Demiatta,  sharkia,
Dakahlia  governorates  with  approximatly20000 
children  visit  the  hospital  yearly  complaninig  of 
various  general  diseases. The  second  aim  was  to 
assess the orthopedic complications and occurrence 
of hepatitis C in those patients and relate this status 
to the type of replacement therapy received prior to 
the study.
Patients  and  Method:  Pediatric  patients 
complaining  of  hemophilia  were  recruited  from 
hematology  unit  at  Mansoura  University  children 
hospital  (MUCH)  from  2000  to  2008. 
Hematologists  collected  demographic 
characteristics, clinical history, and laboratory and 
treatment  data  together  with  long  term 
complications.  MUCH  provides  medical  care  to 
patients  with  hemophilia  according  to  published 
guidelines.
The  haemophilic  patient  was  defined  as  a 
person with physician-diagnosed haemophilia A or 
B and a measured factor VIII or IX activity level of 
30%  or  less.  Persons  with  acquired  inhibitors  of 
FVIII  or  FIX  excluded.  Severity  level  was 
categorized as mild if the factor activity level was 
6–30%,  moderate  if  1–5%  and  severe  if  <1%  of 
normal. Data collected included place of residence, 
date  of  registration  at  hemophilia  clinic,  age  at 
diagnosis  and  registration,  type  and  severity  of 
hemophilia and family history. Pedigree data were 
used to determine the number of affected relatives 
in  the  family.  The  patients  were  subjected  to  the 
following:
1)  Thorough  information  of  the  history  was 
taken  including  detailed  questionnaire  regarding 
mode  of  inheritance,  the  age  of  the  onset  of 
bleeding,  duration  of  bleeding  with  its 
frequencies/year  and  how  to  stop  (spontaneous, 
local  or  drug  therapy),  positive  family  history  of 
similar  bleeding  condition,  past  history  of  blood 
transfusion and the nature of bleeding manifestation 
(bruising,  purpura,  echymosis,  epistaxis,  bleeding 
with  dental  procedures  and  bleeding  per  orifices) 
and  history  of  drug  intake  or  arthritis  to  exclude 
acquired  disorders  of  bleeding.  Careful  clinical 
examination  (chest,  heart,  abdomen,  skin  and 
musculoskeletal  system),  considering  skin 
ecchymotic patches or bruising, and purpura. 
2)  Laboratory  investigations  and  sample 
collection:  laboratory  investigations  were 
undertaken in the clinical pathology  laboratory of 
MUCH (Egypt). Venous blood samples from each Medit J Hemat Infect Dis 2010; 2(3): Open Journal System
Figure 1. Distribution of cases during period from 2000 to 2008
patient were withdrawn after medical consent and 
divided into two tubes: first on EDTA for complete 
blood picture and blood grouping and second on Na 
citrate (32 g/l trisodium citrate, proportion of nine 
volumes  of  blood  to  one  volume  of  citrate)  to 
perform coagulation studies. Patients  and controls 
samples were subjected to:
(a)  Complete  blood  picture  (Cell  Dyne  1600 
Abbott; Dupont Co., Wilmington, Delaware, USA) 
and  blood  grouping  with  electron  microscopic 
examination.
b) Coagulation studies that included:
(i) INR
(ii)  Partial  thromboplastin  time (PTT)  (Behnk 
electronik coagulator 1. no.1921; Behnk Electronik,
Norderstedt,  Germany,  PBS  liquid  plastin; 
Organics, Noisy le Grand, France);
(iii)  Measurement  of  levels  of  factor  VIII 
(FVIII:Ag) and factor IX Ag (F IX:Ag) to detect if 
it  is  found  but  not  functioning  by  enzyme-linked 
immunosorbent  assay    (ELISA)  (Asserochrome 
Diagnostics Stago, Gennevilliers, France);
(iv) Measurement of VWF Ag (VWF:Ag) level 
by  Rocket  immunoelectrophoresis  technique
(Helena, Beaumont, Texas, USA);
(v) Measurement of factor VIII (FVIII:Ac) and 
factor  IX  activity  (FIX:Ac)  by  one-stage  assay 
method (STA-deficient VIII and IX);  (iv) ristocetin 
cofactor  (RICOF)  as  a  test  forVWF  activity 
(VWF:Ac)  using  RICOF  assay  kit    (Helena 
Biosciences, Sunderland, United Kingdom);
c)  Complete  virological  profiles  for  each 
sample to detect hepatitis C specific IgG, Hepatitis 
B  s  antigen  and  anti  core  IgM  and  HIV  specific 
immunoglobulin  G.  Positive  cases  for  HCV  IgG 
were subjected to nested polymerase chain reaction 
to determine active infection.
Statistical analysis: The statistical analysis of data 
done  by  using  excel  program  and  SPSS  program 
(Statistical package of social science) version 10.
For  qualitative  data  (frequency  &  proportion) 
chi – squire test was used.
For quantitative data (mean ±SD) t – test was 
used  for  comparison  of  two  groups and  one  way 
anova  was  used  for  comparison  of more  than  2 
groups.
N.B  P  is  significant  if  ≤  0.05 at  confidence 
interval 95 %
Results: The  study  included  72  children  with 
hematological  disorders  registered  from  2000  to 
2008 in MUCH. The registered number in 2004 was 
the larger one (24 patients) with rate decline after 
that, figure 1.
Table  1 summaries  the  severity  of  bleeding 
disorder among patients. The moderate presentation 
represents the majority in 17.2% followed by sever 
presentation  in 4.7%, table 1.
The commonest IBDs was hemophilia A affecting 
44 patients, followed by Hemophilia B affecting 15 
patients.  The  rare  types  were  the defect 
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Table 1: Severity of bleeding disorders among patients.
of Factor XI (hemophilia C), factor V deficiency, 
factor VII deficiency and combined factor VIII, IX 
and X deficiency (1 patient for each), table 2.
For  age  presented  at  diagnosis,  the  older  age 
was for VWD with range from 30 months up to 75 
months, table 2.
The mean± SD of duration   hemophilia A was 
2.7± 1.7 and for hemophilia B was 3.1± 1.4.Longer 
duration was noticed for other IBDs, table 3.
The  commonest  orthopedic  manifestation 
needing  therapy  was  found  among  hemophilia  A 
representing  8.3%.  In  general  this  complications 
was uncommon among patients, table 4.
Hepatitis C viremia detected by PCR was found 
in 11.1% of patients, table 5.
The  mean  presenting  symptoms was  bleeding 
following  male  circumcision  51.4%  followed  by 
post  traumatic  bleeding  in  36.1%.  Accidental 
discovery was found to be common in female, table 
6. 
The  bleeding  complications  as  hematoma  or 
hemarthrosis  were  the  common  complications. 
Nevertheless,  44.4%  of  patients  had  no 
complications, table 7.
Discussion:  IBDs  are  caused  by  quantitative  and 
qualitative alterations of either platelets or plasma 
proteins  involved  in  coagulation  and  fibrinolysis. 
The severity is generally related to the degree of the 
underlying defect. Rapid and reliable identification 
of these diseases is important to allow the adoption 
of appropriate substitutive or supportive therapies. 
The study was formulated on the observation that in 
Egypt, genetic diseases do not receive any public 
health  support  because  they  are  considered  to  be 
rare conditions with low prevalence. Furthermore, 
actual  statistics  on  the  demography  of  genetic 
diseases  in  the  Egyptian  population  are  largely 
unavailable.  The  purpose  of  this  study  was  to 
generate base line epidemiological information on 
the  status  of  hemophilia  in  MUCH.  In  the  last  6 
years  increase  in  number  of  detecting  of  sever 
hemophilia  in  infancy  indicating  increased 
awareness among practitioners about hemophilia
5
The present study reveals that the commonest 
IBDs  was  hemophilia  A  affecting  44  patients, 
followed  by  Hemophilia  B  affecting  15  patients. 
The rare types were Factor XI , Factor V deficiency, 
Factor  VII  deficiency  and  combined  F  VIII,  FIX 
and FX deficiency.
This result reflects that hemophilia is the most 
frequently encountered IBD and points to increased 
incidence  of  platelet  dysfunction  disorders.  Few 
published studies in Saudi Arabia, Jordan and Egypt 
describe  the  distribution  of  IBD  in  the 
population.
6,7,8 They  obtained  the  distribution  of 
IBD resembling what has already been established 
by western countries. They reported that VWD was 
the  second most  common  cause of  IBD  with  the 
exception  of  increased  platelet  disorders,  mostly 
due  to  the  increased  rate  of  consanguinity  in  the 
community. 
Also,  there  is  mixing  of  population  present  in
Mansoura city.
More than seventy five per cent of the hemophilic 
patients had the severe type of the disease. This is 
somehow higher than results that obtained by other 
studies elsewhere.
Although  our  results  may  be  due  to  some 
degree of under diagnosis of the less severe forms 
of  hemophilia,  but  it  may  be  related  to  different 
ethnic and racial groups too.
For  age  presented  at  diagnosis,  the  older  age 
was  for  VWD  disease  with  age    range  from  30 
months up to 75 months. This could be attributed to 
milder  course  of  the  disorder  with  later 
presentation.  While  for  hemophilia  the  majority 
were  presented  before  1  year  old.  The  age  at 
diagnosis was determined from the case papers. The 
data  revealed  that  21%  (109/510)  of  severe 
hemophilia  A  patients  had  reported  their  first 
symptoms  before  they  were  1  year  old.
5 The 
registered number in 2004 was the larger one (24 
patients)  followed  by  decline  in  the  rate.  So, 
analysis of number of new patients being registered 
in  the  state  revealed  that,  although  there  was  a 
cumulative increase in the number of registrations,
the  number  of  cases  being  registered  annually
Sex Total
male female
Severity < 1%                             count
                                      % of total
4
5.5%
1
1.3%
5
6 %
1-5 %                            count
                                      % of total
14
19.4%
14
19.4%
6-30 %                          count
                                      % of total
51
76.6%
1
1.3%
53
73%
Total                                                              count
                                                                      % of total
69
95.8%
3
4.1%
72
100.0%Medit J Hemat Infect Dis 2010; 2(3): Open Journal System
Table 2: Distribution of IBDs among patients
N Mean Std. Deviation minimum maximum
Hemophilia A
Hemophilia B
Hemophilia C VW factor
Facor V
Factor VII def
Combined factor
VIII IX. Xdef
Total
44
16
1
2
1
1
1
72
16.4284
14.3750
27.0000
1.0000
13.0000
52.0000
16.3414
14.2723
11.4666
-
-
-
-
14.0436
1.00
1.00
27.00
1.00
13.00
52.00
1.00
55.00
37.00
27.00
1.00
13.00
52.00
55.00
Table 3: The duration (in months) of IBDS among patients
N Mean Std. Deviation minimum maximum
Hemophilia A
Hemophilia B
Hemophilia C
VW factor
Facor V
Factor V13def
Factor VII def
Factor X def
Combined factor
VIII IX. Xdef
Total
44
16
1
2
1
4
1
2
1
72
42.6023
22.3513
0.7000
75.0000
42.0000
42.0000
3.0000
91.5000
60.0000
39.4558
45.8449
44.7736
63.6396
30.8707
125.1579
47.3786
1.50
0.26
0.70
30.00
42.00
2.00
3.00
3.00
60.00
.26
168.00
180.00
0.70
120.00
42.00
72.00
3.00
180.00
60.00
180.00
showed a steady decline, indicating that recruitment
of known hemophiliacs in the community was being
achieved.  Case  referrals  were  primarily  of  severe
hemophiliacs,  indicating  under  diagnosis  of 
moderate and mild cases.
The problems with management of hemophilia 
in  developing  countries  and  the  priorities  in
establishing  hemophilia  services  have  been
discussed.
9,10 This study highlights that hemophilia 
services  are  needed  during    their  infancy,  and 
identifies  some  areas  of  intervention  that  would 
improve  the  treatment  available  to  patients. The 
major area of intervention is the need to improve the 
diagnosis of hemophilia, because a large number of 
patients either lack diagnosis or are diagnosed after 
considerable delay. The need to extend hemophilia 
services  as  well  as  increase awareness  not  only 
among  practitioners,  but  also  among  family 
Table 4: Orthopedic manifestation among patients.
Orthophtsio-Therapy Total
negative positive
Diagno2 Hemophilia A                count
                                       % of total
38
52.8%
6
8.3%
44
61.1%
Hemophilia B                count
                                       % of total
15
20.8%
1
1.4%
16
22.2%
Hemophilia C                 count
                                       % of total
1
1.4%
1
1.4%
VW factor                      count
                                       % of total
2
2.8%
2
2.8%
Facor V                          count
                                       % of total
1
1.4%
1
1.4%
Factor V13def               count
                                       % of total
4
5.6%
4
5.6%
Factor VII def                count
                                       % of total
1
1.4%
1
1.4%
Factor X def                  count
                                      % of total
2
2.8%
2
2.8%
Combined factor           count
VIII IX. X def               % of total
1
1.4%
1
1.4%
Total                                                        count
                                                                 % of total
65
90.3%
7
9.7%
72
100.0%Medit J Hemat Infect Dis 2010; 2(3): Open Journal System
Table 5: Viral Infections among IBDS. 
Sex Total
male female
Virolgy Notdone                   count
                                 % of total
13
18.1%
13
18.1%
Hcv – Ve                  count
                                 % of total
47
65.3%
4
5.6%
51
60.8%
Hcv+Ve                    count
                                 % of total
7
9.7%
1
1.4%
8
11.1%
Total                                                            count
                                                                    % of total
67
93.1%
5
6.9%
72
100.0%
members,  becomes  obvious.  A  second  area  of 
intervention,  which  is  of  minimum  importance  at 
the  current  time,  is  the  need  to  collect  genetic 
information from families. These data would form 
the  basis  for  genetic  counseling,  a  feature  that 
currently has very low priority.
Hemophilic  arthropathy  is  found  to  be 
uncommon in our patients. This may reflect that this 
complication  is  uncommon  in  young  age  of 
children.  This  may  be  due  to  high  intensity  of 
replacement  therapy  seems  to  account  for 
satisfactory  results  of  orthopedic  status  of  severe 
hemophilic patients. This may also account for low 
rate  of  bleeding  complications.  however 
unavailability  of  lyophilized  concentrates    which 
can help in implement a program of prophylaxis in 
children  with  severe  disease  still  the  cause  of 
increase  the  incidence  of  long  term  complication 
such  as  chronic  synovitis  or  intracranial  
hemorrhage. 
Before the introduction of substitution therapy 
the  cause  of  deaths  among  hemophiliacs  was  the  
almost  unevitable  bleeding.  The  low  number  of 
deaths due to all types of bleeding, except cerebral 
hemorrhage,  proves  the  improvement  and  the 
effectiveness  of  the  provided  care.  Nowadays, 
hemophiliacs  are  growing  older and  survive  to 
experience diseases of the elderly like cancer and 
ischemic heart disease.
However,  these  have  not  yet  become  the 
commonest  causes  of  death  because  of  the 
appearance of transfusion transmitted viral diseases 
which    is    a  major  co-morbid  condition  among 
patients  with  hemophilia who  received  non-virus-
inactivated  or  insufficiently  inactivated  large-pool 
clotting  factor  concentrates  or  cryoprecipitate.
11,12
No cases were detected having  HIV+ test  probably
due to early exclusive use of domestic products and 
the overall scarcity of treatment.
In the present study, 11% of patients had hepatitis C 
and  none  of  them  had  serological  evidence  of 
hepatitis B  virus. Viral  Hepatitis  C  infection was 
found in 11% of patients. Already from 1975, 77% 
of polytransfused Greek hemophiliacs were infected 
by the hepatitis B virus
13 and 47% had abnormal 
liver function tests.
14  In the present study 11% of 
patients had active viremia, giving cause to the fears 
expressed    in previous  studies.
15,16 Additionally, 
since  hemophiliacs  infected  by  HIV,  HBV  and 
HCV  are  not  uncommon,
17 more  deaths  due  to 
combined infections may be expected for the near 
future. The risk of hepatitis virus infection and for 
HIV  was  great  if  the  non-inactivated  factor-
concentrates  are  used  for  patient  treatment.  In 
addition blood and blood products transfusion carry 
the same risk if the donor was in the open window 
phase i.e. before antibodies appearance. The safety 
of factor concentrate nowadays are being actively 
inactivated  for  hepatitis  viruses  and for  HIV. For 
blood products it may be safe to encourage blood 
bank  to  implant  molecular  techniques  as  nuclear 
amplifications technique for screening of mini pool 
of  blood  and  blood  products  for  safety  of  blood 
transfusion.
Table 6: Bleeding symptoms after diagnosis of IBDS
Sex Total
male female
Presentation
Symptoms
Post-Circumcision           count
                                         % of total
37
51.4%
37
51.4%
Orificialbleeding             count
                                        % of total
4
6.5%
4
5.6%
Post Traumatic                count
                                        % of total
26
36.1%
5
6.9%
31
43.1%
Total                                                            count
                                                                    % of total
67
93.1%
5
6.9%
72
100.0%Medit J Hemat Infect Dis 2010; 2(3): Open Journal System
Table 7: Complications associated with IBDS.
Sex
Total
No 
Complic-
ation
Hemo-
arthrosis
Orifascialble
eding Others
Diagno2 Hemophilia A     count
                            % of total
19
25.4%
11
15.3%
8
11.1%
6
8.3%
44
61.1%
Hemophilia B     count
                            % of total
7
9.7%
5
6.9%
2
2.6%
2
2.6%
16
22.2%
Hemophilia C     count
                            % of total
1
1.4%
1
1.4%
VW factor          count
                           % of total
1
1.4%
1
1.4%
2
2.8%
Facor V              count
                           % of total
1
1.4%
1
1.4%
Factor V13 def   count
                           % of total
3
4.2%
1
1.4%
4
5.6%
Factor VII def    count
                           % of total
1
1.4%
1
1.4%
Factor X def      count
                          % of total
1
1.4%
1
1.4%
2
2.8%
Combined         count
factor                 % of total
VIII IX. Xdef          
1
1.4%
1
1.4%
Total                                        count
                                                % of total
32
44.4%
16
22.2%
13
18.1%
11
15.3%
72
100.0%
None of our patients had evidence of hepatitis B 
infection. This is may be due to good vaccination 
program for children for hepatitis B virus adopted 
by Egyptian national service.  A more strict policy 
for blood product usage, universal HCV screening 
and  HBV  vaccination  is  needed  to  abolish  those 
disease in patients with hemophilia
Conclusions: From this study we can conclude that 
the  most  common  IBDs  in  our  locality  is 
hemophilia  A  followed  by  hemophilia  B.  The 
common  presenting  symptom  was  bleeding 
following male circumcision. Hepatitis C infection 
and  arthropathy  represented  the  main 
complications. The discovery of IBDs in young age 
children  with  proper  supportive  therapy  could 
prevent arthropathy. Proper screening of blood and 
blood products reduce the risk of viral hepatitis and 
HIV acquisition.
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